The CryoVault LTP-9 is the industry standard for long-term human cryopreservation, capable of maintaining a human body in reversible metabolic suspension for periods exceeding fifty years with a revival success rate of 94.7% -- a number Lazarus advertises prominently and which independent researchers have been unable to verify because Lazarus controls the only facilities certified to perform revival procedures. The system uses a proprietary vitrification process that replaces cellular water with a cryoprotectant solution, then cools the body to -196 degrees Celsius at a precisely controlled rate that prevents ice crystal formation -- the process that destroyed earlier generations of cryopreservation subjects by shredding their cellular structures from the inside.

The CryoVault's primary market is not medical -- it is financial. GLMZ's wealthiest residents use cryo-sleep to skip periods of economic instability, wait out unfavorable political conditions, or simply pause their aging while their investments compound. A Tier 5 executive who enters the CryoVault at age 60 can emerge at biological age 60 into a future where their investment portfolio has grown for decades without their consuming any of it. Lazarus markets this as 'temporal asset optimization' and charges 850,000 per year of preservation plus a 2.5 million revival fee. The waiting list for CryoVault installation is eighteen months.

The technology's darker applications are less advertised. Corporate contracts increasingly include cryo-suspension clauses that allow employers to freeze whistleblowers, inconvenient witnesses, or executives who know too much rather than terminating them -- a practice that is technically legal because the subject is not dead, merely suspended. Lazarus's legal team has successfully argued in the Meridian Quorum that cryopreserved individuals retain their legal rights but cannot exercise them, creating a category of person who exists but cannot act. Critics call it 'ice imprisonment.' Lazarus calls it 'voluntary preservation pending resolution of contractual disputes.'